Optimizing the Treatment Sequence From Second-Line to Third-Line Therapy in Patients With Metastatic Colorectal Cancer: Discussion

被引：0
|
作者：
Grothey, Axel
Prager, Gerald W.
Yoshino, Takayuki
Bekaii-Saab, Tanios S.
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2020年 / 18卷 / 01期
关键词：
GLIOBLASTOMA;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：21 / 23
页数：3
相关论文
共 50 条
  • [41] Second-line and third-line chemotherapy in malignant gliomas:: Is there a benefit?
    Pace, A.
    Fabi, A.
    Mirri, A.
    Vidiri, A.
    Cianciulli, A.
    Merola, R.
    Galiè, E.
    Maschio, M.
    Jandolo, B.
    Carapella, C. M.
    NEURO-ONCOLOGY, 2006, 8 (04) : 346 - 346
  • [42] Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy
    Felip, E.
    Gridelli, C.
    Baas, P.
    Rosell, R.
    Stahel, R.
    ANNALS OF ONCOLOGY, 2011, 22 (07) : 1507 - 1519
  • [43] Weekly topotecan as second- or third-line treatment in patients with recurrent or metastatic cervical cancer
    Jaime Coronel
    Lucely Cetina
    Myrna Candelaria
    Aurora González-Fierro
    Daimy Arias
    David Cantu
    Alfonso Dueñas-González
    Medical Oncology, 2009, 26 : 210 - 214
  • [44] Cost-effectiveness analysis of fruquintinib as third-line treatment for patients with metastatic colorectal cancer
    Zhang, Peng-Fei
    Xie, Dan
    Li, Qiu
    TUMORI JOURNAL, 2020, 106 (05): : 400 - 405
  • [45] A Pilot Study of Apatinib as Third-Line Treatment in Patients With Heavily Treated Metastatic Colorectal Cancer
    Liang, Lijun
    Wang, Lei
    Zhu, Panrong
    Xia, Youyou
    Qiao, Yun
    Wu, Jiang
    Zhuang, Wei
    Fei, Jiayan
    Wen, Yixuan
    Jiang, Xiaodong
    CLINICAL COLORECTAL CANCER, 2018, 17 (03) : E443 - E449
  • [46] Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India
    Khan, Samsuddin
    Das, Mrinalini
    Andries, Aristomo
    Deshpande, Alaka
    Mansoor, Homa
    Saranchuk, Peter
    Isaakidis, Petros
    GLOBAL HEALTH ACTION, 2014, 7 : 1 - 6
  • [47] Weekly topotecan as second- or third-line treatment in patients with recurrent or metastatic cervical cancer
    Coronel, Jaime
    Cetina, Lucely
    Candelaria, Myrna
    Gonzalez-Fierro, Aurora
    Arias, Daimy
    Cantu, David
    Duenas-Gonzalez, Alfonso
    MEDICAL ONCOLOGY, 2009, 26 (02) : 210 - 214
  • [48] XELIRI compared with FOLFIRI as a second-line treatment in patients with. metastatic colorectal cancer
    Cui, Chengxu
    Shu, Chang
    Yang, Yi
    Liu, Junbao
    Shi, Shuping
    Shao, Zhujun
    Wang, Nan
    Yang, Ting
    Hu, Songnian
    ONCOLOGY LETTERS, 2014, 8 (04) : 1864 - 1872
  • [49] Raltitrexed plus oxaliplatin in the second-line treatment of metastatic colorectal cancer
    Vyzula, R
    Kocáková, I
    Demlová, R
    Kiss, I
    Dusek, L
    Jarkovsky, J
    NEOPLASMA, 2006, 53 (02) : 119 - 127
  • [50] Metastatic colorectal cancer:: First- and second-line treatment in 2005
    Rougier, P
    Lepère, C
    SEMINARS IN ONCOLOGY, 2005, 32 (06) : S15 - S20
12345